Mast cells regulate myofilament calcium sensitization and heart function after myocardial infarction

Ngkelo et al. use a mast cell–deficient mouse model to reveal a protective role of mast cells in myocardial infarction, through regulation of the cardiac contractile machinery.

[1]  J. J. Walsh,et al.  Mast cell stabilisers. , 2016, European journal of pharmacology.

[2]  J. Kuiper,et al.  The impact of mast cells on cardiovascular diseases. , 2016, European journal of pharmacology.

[3]  O. Schmetzer,et al.  Murine and human mast cell progenitors. , 2016, European journal of pharmacology.

[4]  E. Marbán,et al.  Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. , 2015, The Journal of clinical investigation.

[5]  B. Keavney,et al.  T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients. , 2015, The Journal of clinical investigation.

[6]  S. Herzig,et al.  Hematopoietic Kit Deficiency, rather than Lack of Mast Cells, Protects Mice from Obesity and Insulin Resistance. , 2015, Cell metabolism.

[7]  M. Movsesian.  New pharmacologic interventions to increase cardiac contractility: challenges and opportunities , 2015, Current opinion in cardiology.

[8]  R. Hajjar,et al.  Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment. , 2015, Cell metabolism.

[9]  Sonal Singh,et al.  Compartmentalization Role of A-Kinase Anchoring Proteins (AKAPs) in Mediating Protein Kinase A (PKA) Signaling and Cardiomyocyte Hypertrophy , 2014, International journal of molecular sciences.

[10]  J. Davoust,et al.  Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis. , 2014, The Journal of clinical investigation.

[11]  J. Alpert,et al.  Republished: Clinical implications of the Third Universal Definition of Myocardial Infarction , 2014, Postgraduate Medical Journal.

[12]  U. Rauch,et al.  Role of protease-activated receptors for the innate immune response of the heart. , 2014, Trends in cardiovascular medicine.

[13]  Jonathan P. Davis,et al.  Combined troponin I Ser-150 and Ser-23/24 phosphorylation sustains thin filament Ca(2+) sensitivity and accelerates deactivation in an acidic environment. , 2014, Journal of molecular and cellular cardiology.

[14]  G. Pejler,et al.  Mast cell secretory granules: armed for battle , 2014, Nature Reviews Immunology.

[15]  L. Walker,et al.  Characterization and validation of new tools for measuring site-specific cardiac troponin I phosphorylation. , 2014, Journal of immunological methods.

[16]  D. Kass,et al.  Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β. , 2014, The Journal of clinical investigation.

[17]  S. Werner,et al.  Mast Cells Are Dispensable for Normal and Activin-Promoted Wound Healing and Skin Carcinogenesis , 2013, The Journal of Immunology.

[18]  M. Ruel,et al.  Injectable small intestine submucosal extracellular matrix in an acute myocardial infarction model. , 2013, The Annals of thoracic surgery.

[19]  Xiangru Lu,et al.  Cardiomyocyte-specific overexpression of human stem cell factor protects against myocardial ischemia and reperfusion injury. , 2013, International journal of cardiology.

[20]  D. Henrion,et al.  Prokineticin Receptor‐1 Is a New Regulator of Endothelial Insulin Uptake and Capillary Formation to Control Insulin Sensitivity and Cardiovascular and Kidney Functions , 2013, Journal of the American Heart Association.

[21]  D. Tsiantoulas,et al.  B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction , 2013, Nature Medicine.

[22]  K. Murthy,et al.  Distinctive G Protein-Dependent Signaling by Protease-Activated Receptor 2 (PAR2) in Smooth Muscle: Feedback Inhibition of RhoA by cAMP-Independent PKA , 2013, PloS one.

[23]  V. Barroca,et al.  In situ production of innate immune cells in murine white adipose tissue. , 2012, Blood.

[24]  G. Shi,et al.  Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases. , 2012, Current pharmaceutical design.

[25]  M. Tsai,et al.  Evidence questioning cromolyn’s effectiveness and selectivity as a ‘mast cell stabilizer’ in mice , 2012, Laboratory Investigation.

[26]  K. Clément,et al.  Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes. , 2012, The Journal of clinical endocrinology and metabolism.

[27]  C. Benoist,et al.  Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. , 2011, Immunity.

[28]  K. F. Austen,et al.  Mast cell deficiency, a game of kit and mouse. , 2011, Immunity.

[29]  Ying Ge,et al.  Augmented Phosphorylation of Cardiac Troponin I in Hypertensive Heart Failure* , 2011, The Journal of Biological Chemistry.

[30]  J. Brazin,et al.  Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system. , 2011, Current pharmaceutical design.

[31]  J. S. Janicki,et al.  Tryptase/Protease-Activated Receptor 2 Interactions Induce Selective Mitogen-Activated Protein Kinase Signaling and Collagen Synthesis by Cardiac Fibroblasts , 2011, Hypertension.

[32]  J. S. Janicki,et al.  Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2 (PAR-2) , 2011, Journal of Cell Communication and Signaling.

[33]  R. Moss,et al.  Protein kinase A–induced myofilament desensitization to Ca2+ as a result of phosphorylation of cardiac myosin–binding protein C , 2010, The Journal of general physiology.

[34]  C. Balke,et al.  Cardiac Troponin T, a Sarcomeric AKAP, Tethers Protein Kinase A at the Myofilaments* , 2010, The Journal of Biological Chemistry.

[35]  B. Cousin,et al.  Adipose Tissue as a Dedicated Reservoir of Functional Mast Cell Progenitors , 2010, Stem cells.

[36]  N. Mackman,et al.  Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion Injury , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[37]  J. Reagan,et al.  G-Protein-Coupled Receptor 35 Is a Target of the Asthma Drugs Cromolyn Disodium and Nedocromil Sodium , 2010, Pharmacology.

[38]  Keshava Rajagopal,et al.  Teaching old receptors new tricks: biasing seven-transmembrane receptors , 2010, Nature Reviews Drug Discovery.

[39]  S. Sadayappan,et al.  Phosphorylation and function of cardiac myosin binding protein-C in health and disease. , 2010, Journal of molecular and cellular cardiology.

[40]  S. Cortassa,et al.  Calcium sensitivity, force frequency relationship and cardiac troponin I: critical role of PKA and PKC phosphorylation sites. , 2010, Journal of molecular and cellular cardiology.

[41]  I. Weissman,et al.  Distinguishing mast cell and granulocyte differentiation at the single-cell level. , 2010, Cell stem cell.

[42]  C. Kahn,et al.  Transplantation of adipose tissue and stem cells: role in metabolism and disease , 2010, Nature Reviews Endocrinology.

[43]  G. Koh,et al.  Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells. , 2010, Blood.

[44]  S. Matecki,et al.  Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy , 2010, Proceedings of the National Academy of Sciences.

[45]  K. Clément,et al.  Deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice , 2009, Nature Medicine.

[46]  Guoping Wang,et al.  Ischaemia/reperfusion induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF‐κB pathway , 2009, International journal of experimental pathology.

[47]  P. Kovanen.  Mast cells in atherogenesis: Actions and reactions , 2009, Current atherosclerosis reports.

[48]  M. Hesse,et al.  c-kit expression identifies cardiovascular precursors in the neonatal heart , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Ward,et al.  Phosphorylation of the cAMP-dependent Protein Kinase (PKA) Regulatory Subunit Modulates PKA-AKAP Interaction, Substrate Phosphorylation, and Calcium Signaling in Cardiac Cells* , 2008, Journal of Biological Chemistry.

[50]  R. Guyton,et al.  PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts. , 2007, American journal of physiology. Heart and circulatory physiology.

[51]  R. Moss,et al.  Differential Roles of Cardiac Myosin-Binding Protein C and Cardiac Troponin I in the Myofibrillar Force Responses to Protein Kinase A Phosphorylation , 2007, Circulation research.

[52]  T. Arumugam,et al.  Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. , 2006, Journal of the National Cancer Institute.

[53]  Donna H. Wang,et al.  Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[54]  J. S. Janicki,et al.  Rat cardiac mast cell maturation and differentiation following acute ventricular volume overload , 2006, Inflammation Research.

[55]  S. Verma,et al.  Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. , 2006, The Journal of clinical investigation.

[56]  R. Solaro,et al.  Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemia-reperfusion dysfunction. , 2005, American journal of physiology. Heart and circulatory physiology.

[57]  C. Chen,et al.  Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.

[58]  I. Weissman,et al.  Identification of mast cell progenitors in adult mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Ajay M Shah,et al.  Regulation of cardiac contractile function by troponin I phosphorylation. , 2005, Cardiovascular research.

[60]  Pamela S Douglas,et al.  Distinct mouse coronary anatomy and myocardial infarction consequent to ligation , 2005, Coronary artery disease.

[61]  M. Entman,et al.  Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts , 2005, The Journal of pathology.

[62]  S. Coughlin,et al.  Regulated Shedding of PAR1 N-terminal Exodomain from Endothelial Cells* , 2004, Journal of Biological Chemistry.

[63]  A. Erdei,et al.  Regulation of mast cell activation by complement-derived peptides. , 2004, Immunology letters.

[64]  D. Ward,et al.  A cross-linking study of the N-terminal extension of human cardiac troponin I. , 2003, Biochemistry.

[65]  H. Tokumitsu,et al.  Hsp90 is a direct target of the anti-allergic drugs disodium cromoglycate and amlexanox. , 2003, The Biochemical journal.

[66]  B. Sykes.  Pulling the calcium trigger , 2003, Nature Structural Biology.

[67]  I. Kulikovskaya,et al.  Effect of extraction of myosin binding protein C on contractility of rat heart. , 2003, American journal of physiology. Heart and circulatory physiology.

[68]  K. Koike,et al.  IL-9 Enhances the Growth of Human Mast Cell Progenitors Under Stimulation with Stem Cell Factor1 , 2003, The Journal of Immunology.

[69]  L. Pénicaud,et al.  Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. , 2003, Biochemical and biophysical research communications.

[70]  D. Taub,et al.  Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. , 2002, Blood.

[71]  H. Tokumitsu,et al.  Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein. , 2002, Biochemical and biophysical research communications.

[72]  A. Ahluwalia,et al.  Protease-Activated Receptor-2 Activation Causes EDHF-Like Coronary Vasodilation: Selective Preservation in Ischemia/Reperfusion Injury: Involvement of Lipoxygenase Products, VR1 Receptors, and C-Fibers , 2002, Circulation research.

[73]  C. Stroh,et al.  Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. , 2002, The Journal of investigative dermatology.

[74]  K. McDonald,et al.  Power Output Is Increased After Phosphorylation of Myofibrillar Proteins in Rat Skinned Cardiac Myocytes , 2001, Circulation research.

[75]  R. Marthan,et al.  Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. , 2001, Journal of applied physiology.

[76]  I Kulikovskaya,et al.  Multiple structures of thick filaments in resting cardiac muscle and their influence on cross-bridge interactions. , 2001, Biophysical journal.

[77]  C. Napoli,et al.  Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Gautel,et al.  cAPK‐phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin‐S2 in an on‐off fashion , 1999, FEBS letters.

[79]  P. Rosevear,et al.  NMR analysis of cardiac troponin C‐troponin I complexes: effects of phosphorylation , 1999, FEBS letters.

[80]  M. Lindsey,et al.  Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. , 1998, Circulation.

[81]  D. Payan,et al.  Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. , 1997, The Journal of clinical investigation.

[82]  S. Coughlin,et al.  The Cloned Thrombin Receptor Is Necessary and Sufficient for Activation of Mitogen-activated Protein Kinase and Mitogenesis in Mouse Lung Fibroblasts , 1996, The Journal of Biological Chemistry.

[83]  K. Zsebo,et al.  Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. , 1992, Journal of immunology.

[84]  C. Agustí,et al.  Identification of mast cells in bronchoalveolar lavage fluid , 1991, Allergy.

[85]  Y. Kitamura,et al.  Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. , 1978, Blood.

[86]  J. S. Janicki,et al.  The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling. , 2015, Methods in molecular biology.

[87]  A. Ibrahim,et al.  Acute myocardial infarction. , 2014, Critical care clinics.

[88]  S. Phan,et al.  Cardiovascular , Pulmonary and Renal Pathology Role of Stem Cell Factor and Bone Marrow-Derived Fibroblasts in Airway Remodeling , 2010 .

[89]  R. Solaro,et al.  Heart failure, ischemia/reperfusion injury and cardiac troponin. , 2007, Advances in experimental medicine and biology.

[90]  B. Sykes,et al.  Structural based insights into the role of troponin in cardiac muscle pathophysiology , 2004, Journal of Muscle Research & Cell Motility.

[91]  M. Hollenberg,et al.  Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[92]  T. Zuberbier,et al.  Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. , 2000, The Journal of investigative dermatology.